See more : Simplo Technology Co., Ltd. (6121.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Akanda Corp. (AKAN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Akanda Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Fairfax India Holdings Corporation (FIH-U.TO) Income Statement Analysis – Financial Results
- HEARTSEED INC (219A.T) Income Statement Analysis – Financial Results
- Towerstream Corporation (TWER) Income Statement Analysis – Financial Results
- Azplanning Co.,Ltd. (3490.T) Income Statement Analysis – Financial Results
- Atam Valves Limited (ATAM.BO) Income Statement Analysis – Financial Results
Akanda Corp. (AKAN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.akandacorp.com
About Akanda Corp.
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 2.16M | 2.62M | 41.43K | 2.06K | 0.00 |
| Cost of Revenue | 2.05M | 649.88K | 756.16K | 1.81K | 198.82K |
| Gross Profit | 111.45K | 1.97M | -714.73K | 253.00 | -198.82K |
| Gross Profit Ratio | 5.16% | 75.19% | -1,725.10% | 12.27% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 5.88M | 19.85M | 5.81M | 1.36M | 702.41K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.88M | 19.85M | 5.81M | 1.36M | 702.41K |
| Other Expenses | 4.28M | 3.60M | 309.02K | 307.30K | 198.82K |
| Operating Expenses | 10.16M | 23.45M | 6.12M | 1.67M | 901.24K |
| Cost & Expenses | 12.21M | 22.80M | 6.88M | 1.67M | 901.24K |
| Interest Income | 39.00 | 886.00 | 26.75K | 10.19K | 401.00 |
| Interest Expense | 255.66K | 115.32K | 1.09M | 645.16K | 493.81K |
| Depreciation & Amortization | 4.28M | 3.60M | 309.02K | 248.74K | 198.82K |
| EBITDA | -27.74M | -4.52M | -2.15M | -1.41M | -702.01K |
| EBITDA Ratio | -1,284.03% | -626.47% | -15,683.67% | -68,212.22% | 0.00% |
| Operating Income | -10.05M | -20.18M | -6.83M | -1.67M | -901.24K |
| Operating Income Ratio | -465.33% | -770.18% | -16,494.24% | -80,787.34% | 0.00% |
| Total Other Income/Expenses | -22.22M | 11.94M | 96.45K | -634.87K | -493.41K |
| Income Before Tax | -32.28M | -8.24M | -8.13M | -2.30M | -1.39M |
| Income Before Tax Ratio | -1,494.18% | -314.37% | -19,625.88% | -111,569.88% | 0.00% |
| Income Tax Expense | 0.00 | -8.63M | 1.09M | 645.40K | 493.81K |
| Net Income | -32.28M | 397.05K | -9.22M | -2.95M | -1.89M |
| Net Income Ratio | -1,494.18% | 15.16% | -22,263.84% | -142,869.59% | 0.00% |
| EPS | -7.16 | 4.59 | -127.66 | -40.77 | -26.14 |
| EPS Diluted | -7.16 | 4.59 | -127.66 | -40.77 | -26.14 |
| Weighted Avg Shares Out | 4.51M | 86.59K | 72.26K | 72.26K | 72.26K |
| Weighted Avg Shares Out (Dil) | 4.51M | 86.59K | 72.26K | 72.26K | 72.26K |
Akanda Announces Stock Consolidation
London, United Kingdom--(Newsfile Corp. - May 21, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, reported that it expects to implement a 1-for-40 reverse stock split on its ordinary shares effective May 23,...
Akanda Announces Closing of Subsequent Registered Direct Offering
London, United Kingdom--(Newsfile Corp. - May 20, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has closed its previously announced second registered direct offering for the sale and issuance...
Akanda Corp. Announces Subsequent Registered Direct Offering
London, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has entered into a second securities purchase agreement with an accredited investor whereby the...
Akanda Announces Closing of Registered Direct Offering
London, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has closed its previously announced registered direct offering for the sale and issuance of...
Akanda Corp. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
London, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has entered into a securities purchase agreement with an accredited investor whereby the investor has...
Akanda Corp receives non-compliance notice from Nasdaq
Akanda Corp (NASDAQ: AKAN) is in focus this morning after receiving a notice of non-compliance from Nasdaq. Akanda fails to satisfy the Nasdaq listing requirements The deficiency notification was issued to the international medical cannabis company because it failed to...
Why Is Akanda (AKAN) Stock Up 164% Today?
Akanda (NASDAQ: AKAN ) stock is heading higher on Friday despite the cannabis company getting a non-compliance notice from the Nasdaq Exchange. The issue here is AKAN stock not meeting the minimum stockholders' equity requirement to remain on the Nasdaq Exchange.
Akanda Corp. Receives Notice of Non-Compliance from NASDAQ
London, United Kingdom--(Newsfile Corp. - May 16, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), announced that it has received a deficiency notification letter from the Nasdaq Listing Qualifications Department on May 14, 2024, due to non-compliance with...
Akanda Corp Announces Settlement Agreement with Former CEO Tejinder Virk
London, United Kingdom--(Newsfile Corp. - May 13, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), today announced a settlement agreement with former chief executive officer and director, Tejinder Virk, concluding a series of disputes that commenced following Mr....
Akanda Corp. Announces Plans to Be Among International First Movers Pending Completion of Landmark Change in US Drug Policy
London, United Kingdom--(Newsfile Corp. - May 10, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announces it is actively following the landmark change in federal US policy to reschedule cannabis under the...
Source: https://incomestatements.info
Category: Stock Reports